Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcomes compared to best supportive care among AGC patients who received at least two prior regimens. | Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses